Cargando…
Current Opportunities and Challenges of Magnetic Resonance Spectroscopy, Positron Emission Tomography, and Mass Spectrometry Imaging for Mapping Cancer Metabolism In Vivo
Cancer is known to have unique metabolic features such as Warburg effect. Current cancer therapy has moved forward from cytotoxic treatment to personalized, targeted therapies, with some that could lead to specific metabolic changes, potentially monitored by imaging methods. In this paper we address...
Autores principales: | Lin, Gigin, Chung, Yuen-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958648/ https://www.ncbi.nlm.nih.gov/pubmed/24724090 http://dx.doi.org/10.1155/2014/625095 |
Ejemplares similares
-
Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics—Relevance to Glioma
por: Chiang, Gloria C., et al.
Publicado: (2018) -
Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
por: Oldan, Jorge Daniel, et al.
Publicado: (2018) -
Four decades of mapping and quantifying neuroreceptors at work in vivo by positron emission tomography
por: Gjedde, Albert, et al.
Publicado: (2022) -
Tandem Mass Spectrometry as an Independent
Method for Corroborating Fluorine-18 Radioactivity Measurements in
Positron Emission Tomography
por: Shetty, H. Umesha, et al.
Publicado: (2022) -
Statistical Parametric Mapping in Amyloid Positron Emission Tomography
por: Smith, Natasha M., et al.
Publicado: (2022)